Re-challenge of Platinum-based Chemotherapy for Platinum-refractory Patients with Recurrent or Metastatic Head and Neck Cancer: Claims Data Analysis in Japan
# Background The role of platinum rechallenge in head and neck cancer (HNC) has not yet been fully evaluated. # Objectives It is our goal to assess the real-world treatment patterns and usefulness of platinum rechallenge in patients with platinum-refractory recurrent or metastatic HNC receiving pla...
Saved in:
| Main Authors: | Makoto Tahara, Issei Doi, Tatsunori Murata, Sari Mishina, Shinji Takai, Hirokazu Kaneko |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Columbia Data Analytics, LLC
2020-05-01
|
| Series: | Journal of Health Economics and Outcomes Research |
| Online Access: | https://doi.org/10.36469/jheor.2020.12853 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Emerging Role of Lenvatinib in Treating Platinum-Refractory Head and Neck Cancer in Resource-Limited Settings
by: Avinash Khadela, et al. -
Avelumab for platinum-ineligible/refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck: phase Ib results from the JAVELIN Solid Tumor trial
by: Nicolas Penel, et al.
Published: (2021-10-01) -
A part of monography about platinum and platinum metals
by: K. K. Klaus
Published: (2007-06-01) -
Endovascular neural stimulation with platinum and platinum black modified electrodes
by: Alexander R. Harris, et al.
Published: (2025-03-01) -
Nivolumab in platinum-refractory unresectable locally advanced squamous cell carcinoma of the head and neck: A case report and literature review
by: M.S. Ruban, et al.
Published: (2025-03-01)